Latest Period
Q2 2026
Security Snapshot
JUPITER NEUROSCIENCES, INC. - Common Stock, par value $0.0001 per share (JUNS) Institutional Ownership
CUSIP: 48208B203
13F Institutional Holders and Ownership History from Q4 2024 to Q2 2026
Institutions Reporting
13
Shares (Excl. Options)
1,254,220
Price
$0.21
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Symbol
- JUNS on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 1,254,220
- Total 13F value
- $270,430
- Portfolio coverage rank
- 0%
- Share change
- +318,121
- Value change
- +$31,892
- Number of holders
- 13
- Shares outstanding
- 768,017
- SEC-reported price per share
- $0.08
- Insider filing price
- $0.08
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- JUNS - JUPITER NEUROSCIENCES, INC. - Common Stock, par value $0.0001 per share is tracked under CUSIP 48208B203.
- 13 institutions reported positions in Q2 2026.
- 1 significant owner is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 10 to 13 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $716,138 to $270,430.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 13 institutions filings for Q2 2026.
Security key
48208B203
Latest holder period
Q2 2026
13F holders
13
13D/G owners
1
CIK / CUSIP context first
Open Q2 2026 holders
JUNS full holder history
JUPITER NEUROSCIENCES, INC. SEC filings
JUPITER NEUROSCIENCES, INC. company facts
JUPITER NEUROSCIENCES, INC. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 48208B203:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
1
Security
JUNS
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| PharmAla Biotech Holdings Inc. | 17% | $10,629 | 132,867 | PharmAla Biotech Holdings Inc. | 20 Aug 2026 |
As of 30 Jun 2026, 13 institutional investors reported holding 1,254,220 shares of JUPITER NEUROSCIENCES, INC. - Common Stock, par value $0.0001 per share (JUNS). This represents 163% of the company’s total 768,017 outstanding shares.
13F concentration
Top 16 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
163%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| JANE STREET GROUP, LLC | 69% | 533,395 | 0% | $114,253 | |
| Virtu Financial LLC | 30% | 231,240 | +1603% | 0% | $50,000 |
| GEODE CAPITAL MANAGEMENT, LLC | 20% | 156,127 | -26% | 0% | $33,441 |
| VANGUARD CAPITAL MANAGEMENT LLC | 17% | 128,042 | -64% | 0% | $27,401 |
| VANGUARD FIDUCIARY TRUST CO | 11% | 84,173 | -4.1% | 0% | $18,013 |
| XTX Topco Ltd | 4.3% | 32,770 | 0% | $7,019 | |
| Tower Research Capital LLC (TRC) | 3.7% | 28,786 | 0% | $6,166 | |
| NORTHERN TRUST CORP | 3.3% | 25,346 | 0% | 0% | $5,429 |
| StoneX Group Inc. | 2.7% | 20,602 | 0% | $5,678 | |
| LEVEL FOUR ADVISORY SERVICES, LLC | 1.3% | 10,000 | 0% | $2,142 | |
| VESTOR CAPITAL, LLC | 0.29% | 2,193 | 0% | 0% | $557 |
| MidFirst Bank | 0.13% | 1,000 | 0% | 0% | $214 |
| CITIGROUP INC | 0.07% | 546 | 0% | $117 | |
| UBS Group AG | 0% | 0 | -100% | $0 | |
| Yorkville Advisors Global, LP | 0% | 0 | -100% | $0 | |
| CITADEL ADVISORS LLC | 0% | 0 | -100% | $0 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
7
Latest
Q2 2026
Rows shown
1-7 of 7
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 1,254,220 | $270,430 | +$31,892 | $0.21 | 13 |
| 2026 Q1 | 1,904,891 | $716,138 | +$337,776 | $0.38 | 10 |
| 2025 Q4 | 638,871 | $651,953 | +$241,375 | $1.02 | 12 |
| 2025 Q3 | 1,359,565 | $2,392,900 | +$2,278,466 | $1.76 | 9 |
| 2025 Q2 | 65,022 | $66,322 | -$265,706 | $1.02 | 2 |
| 2025 Q1 | 377,975 | $230,507 | +$221,750 | $0.61 | 7 |
| 2024 Q4 | 5,076 | $54,314 | +$54,314 | $10.70 | 3 |